Stay updated on Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    No significant changes to the core content; the study details, eligibility criteria, and outcomes appear unchanged, with only minor visual/layout adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-10-30T14:44:30.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    29 days ago
    Change Detected
    Summary
    Core content updated with an operating-status notice and a version upgrade from v3.0.2 to v3.2.0.
    Difference
    3%
    Check dated 2025-10-02T01:34:28.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    Update: version bumped from v3.0.2 to v3.1.0; no substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-30T11:52:47.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Version bumped from v3.0.1 to v3.0.2; Back to Top link removed.
    Difference
    0.2%
    Check dated 2025-09-15T00:28:51.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.
    Difference
    0.2%
    Check dated 2025-09-07T20:51:18.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated to include new facility names and locations, as well as a list of publications related to renal cell carcinoma. Notably, several specific locations in South Korea, Russia, and other countries have been added, while some previously listed locations have been removed.
    Difference
    22%
    Check dated 2025-08-31T12:59:26.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial page.